Yuchen MD - Genetron Holdings Chief Officer
| GTHDelisted Stock | USD 0.94 0.02 2.08% |
Insider
Yuchen MD is Chief Officer of Genetron Holdings
| Age | 46 |
| Phone | 86 10 5090 7500 |
| Web | https://www.genetronhealth.com |
Genetron Holdings Management Efficiency
The company has Return on Asset of (0.352) % which means that on every $100 spent on assets, it lost $0.352. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.922) %, meaning that it generated no profit with money invested by stockholders. Genetron Holdings' management efficiency ratios could be used to measure how well Genetron Holdings manages its routine affairs as well as how well it operates its assets and liabilities.Genetron Holdings has 158.57 M in debt with debt to equity (D/E) ratio of 0.18, which may show that the company is not taking advantage of profits from borrowing. Genetron Holdings has a current ratio of 2.77, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Genetron to invest in growth at high rates of return.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Ian Anderson | Aclaris Therapeutics | N/A | |
| William Pitchford | Inotiv Inc | 69 | |
| John DSA | Inotiv Inc | 57 | |
| Matt Stauffer | Biodesix | N/A | |
| Kevin Theriault | Sotera Health Co | N/A | |
| Camilla Zuckero | Castle Biosciences | N/A | |
| Peter Kissinger | Inotiv Inc | 79 | |
| MD FACR | Exagen Inc | N/A | |
| Sarah Ashby | Psychemedics | N/A | |
| Dr III | Biodesix | 53 | |
| Paul Kearney | Sera Prognostics | 56 | |
| Robert Doody | Aclaris Therapeutics | N/A | |
| Michael McGarrity | MDxHealth SA ADR | 61 | |
| Robert Hauzie | Sotera Health Co | N/A | |
| Robert Cawthorn | Biodesix | 87 | |
| MingChou Lee | Exagen Inc | N/A | |
| DVM DiplomateACVP | Inotiv Inc | 57 | |
| Paul Marr | MDxHealth SA ADR | N/A | |
| Sally Turner | Sotera Health Co | N/A | |
| Annette Baumgartner | Psychemedics | N/A | |
| Gary Pestano | Biodesix | 57 | |
Management Performance
| Return On Equity | -0.92 | |||
| Return On Asset | -0.35 |
Genetron Holdings Leadership Team
Elected by the shareholders, the Genetron Holdings' board of directors comprises two types of representatives: Genetron Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genetron. The board's role is to monitor Genetron Holdings' management team and ensure that shareholders' interests are well served. Genetron Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genetron Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hai MD, Chief CoFounder | ||
| Sizhen Wang, CEO CoFounder | ||
| Ce Xu, Chief Officer | ||
| Hai Yan, Chief CoFounder | ||
| Lily Liu, Chief Officer | ||
| YunFu Hu, Chief Officer | ||
| Yuchen MD, Chief Officer | ||
| WeiWu He, CoFounder Emeritus | ||
| Yong Liang, Chief Officer | ||
| Victoria Lei, Chief Officer |
Genetron Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genetron Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.92 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (1.24) % | |||
| Operating Margin | (0.87) % | |||
| Current Valuation | 102.87 M | |||
| Shares Outstanding | 31.62 M | |||
| Shares Owned By Insiders | 6.82 % | |||
| Shares Owned By Institutions | 12.51 % | |||
| Number Of Shares Shorted | 20.78 K | |||
| Price To Book | 1.68 X |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Genetron Stock
If you are still planning to invest in Genetron Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genetron Holdings' history and understand the potential risks before investing.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |